Search

everythinglearnresearchcommunity

for

Search:↓

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Intralesional methotrexate effectively treats alopecia areata by reducing TNF-α levels, leading to hair regrowth.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Azelaic acid 20% cream works well for treating scalp alopecia areata and can be an alternative to clobetasol ointment.

Genetic testing is crucial before giving azathioprine to avoid severe side effects.

Contact immunotherapy can improve hair regrowth in alopecia areata patients.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

A new hair loss treatment using dissolving microneedles was found to speed up hair growth and was more effective than daily use of common hair growth drugs.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

AcD scaffolds improve tissue repair and regeneration by combining stem cells with a supportive matrix.

Two microRNAs in stem cell exosomes help treat hair loss by targeting a specific signaling pathway.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

The role of γδT-cells in causing alopecia areata remains unclear.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.